Evolution Wealth Advisors, LLC Bio Atla, Inc. Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$19.0 - $30.95 $2,090 - $3,404	-110 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$29.44 - $43.74 $3,150 - $4,680	-107 Reduced 49.31%	110 $3,000
Q1 2021 Apr 20, 2021	SELL	$32.41 - $70.91 $2,041 - $4,467	-63 Reduced 22.5%	217 $11,000
Q4 2020 Feb 02, 2021	BUY	$31.02 - $35.16 $8,685 - $9,844	280 New	280 $10,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.